Did you know "InformationOfThings.com" was purchased for $9 and sold for $4500? DNDiary posts daily Godaddy closeout domain lists. These lists are well researched and carefully handpicked. A closeout domain can be purchased from Godaddy for registration fees plus one year renewal charges. So for around $20, you can pick a domain name and then pitch it to end users. Closeout domains take around 5-7 days to land in your account. For more information on domain investing, please visit NamePros.com.

Tuesday, January 17, 2017

Daily Godaddy Closeout Domain Picks #195

Click on the link to check domain availability. Always check previous posts as many domain names are still available.

NOTE: Due to a bug, sometimes Godaddy will show you a domain name as "already taken" even though it is actually available for purchase. To get around this, change your location/language to another country and then switch back to your default/native location. Now click on the link from my domain lists again to check its availability.

FacultyPool.com
RacingWizard.com
LocalBookers.com
MagnumWraps.com
TomatoWoods.com
AustereSoft.com
ToxicProof.com
CreedFusion.com
Radiopoly.com
OrbitEstates.com
MicroGrocer.com
GloryMode.com
CoachNexus.com
PartShore.com
EncryptedBit.com
BudDiary.com
EcoLooks.com
WritersCreed.com
FaithUnit.com
IndieTrainer.com
EpilogueMag.com
PollGuide.com
SwiftShows.com
DevilWines.com
FrontCurve.com
ArtOfStudies.com
DollarKart.com
PaladinCity.com
DoubleFuel.com
AtomicCart.com
ZestWork.com
HippieStudio.com
JapanTenders.com
CombatEngine.com
ColorSerum.com
MazeSquare.com
VectorFactor.com
NitroWine.com
ExamMania.com
TastyPunch.com
PhotoAnatomy.com
PoolPanda.com
MemoryTower.com
GameDongle.com
PicHash.com
FitnessScan.com
HtmlOnly.com
CinemaCherry.com
OrthoCase.com
BossEngine.com
NewMedicals.com
NeedleVR.com
MythMag.com
CobraGuitars.com
CinemaWizard.com
EquiChoices.com
NectarFlow.com
UtopiaPrints.com
SigmaTower.com
EpicCruising.com
WishMovies.com
NextCctv.com
TurboPaints.com
PythonTuts.com
NovaCandles.com
AirReactor.com
Topender.com

0 comments:

Post a Comment